Watch Ticker

CytomX Therapeutics, Inc.

Go to CytomX Therapeutics, Inc. Website

$2.45

0.06 (2.51%)

Live

Previous Close

$2.39

Day Range

$0 - $0

Previous Day Range

$2.345 - $2.4

Market Cap

$370.2 million USD

Day Vol.

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Calidi Biotherapeutics is developing a groundbreaking genetic medicine platform using engineered viruses to precisely target and treat metastatic cancers, with promising preclinical data presented at AACR and ASCO conferences.

Related tickers: CLDI, VRTX, IBRX, CRSP, CTMX.

Read Full Article

Cytomx Therapeutics - CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

CytomX Therapeutics and Moderna presented preclinical data on an mRNA-encoded masked IL-12 molecule, which showed potent anti-tumor activity with enhanced tolerability.

Related tickers: CTMX, MRNA.

Read Full Article

Trending Tickers

Please sign in to view